Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Raw Materials (2017 - 2025)

Historic Raw Materials for Dexcom (DXCM) over the last 13 years, with Q4 2025 value amounting to $257.6 million.

  • Dexcom's Raw Materials fell 2124.73% to $257.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $257.6 million, marking a year-over-year decrease of 2124.73%. This contributed to the annual value of $257.6 million for FY2025, which is 2124.73% down from last year.
  • Latest data reveals that Dexcom reported Raw Materials of $257.6 million as of Q4 2025, which was down 2124.73% from $266.0 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Raw Materials registered a high of $366.0 million during Q1 2025, and its lowest value of $87.5 million during Q1 2021.
  • Over the past 5 years, Dexcom's median Raw Materials value was $244.4 million (recorded in 2023), while the average stood at $226.9 million.
  • In the last 5 years, Dexcom's Raw Materials skyrocketed by 10772.53% in 2021 and then plummeted by 2124.73% in 2025.
  • Over the past 5 years, Dexcom's Raw Materials (Quarter) stood at $145.2 million in 2021, then increased by 9.5% to $159.0 million in 2022, then skyrocketed by 100.94% to $319.5 million in 2023, then rose by 2.38% to $327.1 million in 2024, then fell by 21.25% to $257.6 million in 2025.
  • Its Raw Materials stands at $257.6 million for Q4 2025, versus $266.0 million for Q3 2025 and $346.1 million for Q2 2025.